Purpose: To identify the pertinent issues to be addressed in successfully implementing IMRT using sequential tomotherapy into clinical reality and presenting the maturation of quality assurance (QA) programs for both the delivery system and patient treatments that allow routine clinical use of the system.
Materials And Methods: Initially, a cubic phantom containing silver halide film was exposed to the entire treatment before patient treatment. The processed films were digitized with a laser densitometer and the dose distributions were compared with that generated by the planning system. Later, software that calculates the dose delivered to any phantom employing the intensity patterns developed in the inverse planning system for an individual patient was implemented for point checks of dose. A measurement phantom for use with this software was developed and evaluated on a large number of patients. Invasive fixation was used for all cranial patients initially. To use sequential tomotherapy for other sites and larger targets, noninvasive immobilization systems using two types of thermoplastic masks for cranial targets and reusable, evacuated body cradles were evaluated for positional accuracy and suitability for use with port films for patient QA.
Results: The program for equipment validation is divided into daily, weekly, and monthly programs that add only small amounts of time to routine QA programs. For the first 15 patients treated with this modality, the maximum dose measured on the film was within 5% of that predicted by the planning computer. The prescription isodose line was measured in the anteroposterior and lateral dimensions and the average discrepancy between measured and predicted was less than 2 mm. For an isodose line between 50% and 70% of the prescribed dose, the agreement was better than 3 mm. Success with the volume QA program was followed by a point check QA program that reduced the time required for individual patient QA from days to hours. Phantom measurements compared with computer predictions for 588 data points resulted in only 8% being outside a +/-5% criterion. These cases were identified and allow a further reduction in the frequency of tests. Thermoplastic mask materials have adequate restraint characteristics for use with the system and port films on 21 patients resulted in one standard deviation = 1.3 mm. Body cradles are less accurate and require more frequent port films. A QA system that reduces the frequency of port films was developed.
Conclusions: The evolution of sequential tomotherapy in our department has been from a maximum of 3 cranial patients per day with invasive fixation to 60 patients per day for treatment of cranial, head-and-neck, and prostate tumors using different immobilization techniques. With proper preparation and refinement of tools used in commissioning and validation, sequential tomotherapy IMRT can become a routine clinical treatment modality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0360-3016(03)00097-x | DOI Listing |
Transl Oncol
January 2025
Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, PR China. Electronic address:
Objectives: To evaluate the efficacy and the incidence of symptomatic radiation pneumonitis (RP) of the adaptive radiation strategy with V20 limitation in stage III non-small cell lung cancer (NSCLC) patients receiving concurrent immunotherapy and radiotherapy Materials and Methods: We retrospectively reviewed stage III NSCLC patients received thoracic radiation with or without immunotherapy from January 2015 to September 2024 in the Third Xiangya Hospital. The overall survival (OS), progression free survival (PFS), objective response rate (ORR), and the incidence of symptomatic RP were compared among patients stratified by the sequential of immunotherapy and radiotherapy.
Results: 45 patients received concurrent immunotherapy and radiotherapy with application of the adaptive radiation strategy (the CIR group).
Strahlenther Onkol
October 2024
Department of Radiation Oncology, Münster University Hospital, Albert-Schweitzer-Campus 1, Building A1, 48149, Münster, Germany.
Purpose: This study aimed to analyze treatment-related risk factors for sensorineural hearing loss (SNHL) and an indication for hearing aids (IHA) in medulloblastoma patients after craniospinal radiotherapy (CSRT) and platin-based chemotherapy (PCth).
Methods: A total of 58 patients (116 ears) with medulloblastoma and clinically non-relevant pre-treatment hearing thresholds were included. Cranial radiotherapy and PCth were applied sequentially according to the HIT 2000 study protocol or post-study recommendations, the NOA-07 protocol, or the PNET (primitive neuroectodermal tumor) 5 MB therapy protocol.
Front Cardiovasc Med
October 2024
Department of Radiation Oncology, Shidong Hospital, Yangpu District, Shanghai, China.
Background: Primary pericardial mesothelioma (PMPM) is a rare, aggressive, and lethal form of cancer. Due to its rarity, low incidence and poor prognosis, PMPM has no accepted standard-of-care treatment options with management and outcomes often extrapolated from diffuse pleural mesothelioma. Disease-specific studies are needed to better define PMPM.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
September 2024
Department of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324, Jing Six Road, Jinan, Shandong, 250021, China.
J Appl Clin Med Phys
September 2024
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Background: Failure mode and effects analysis (FMEA) is a valuable tool for radiotherapy risk assessment, yet its outputs might be unreliable due to failures not being identified or due to a lack of accurate error rates.
Purpose: A novel incident reporting system (IRS) linked to an FMEA database was tested and evaluated. The study investigated whether the system was suitable for validating a previously performed analysis and whether it could provide accurate error rates to support the expert occurrence ratings of previously identified failure modes.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!